Macrophages are one of the most abundant populations of leukocytes in the body. They carry out important roles in innate immunity and inflammation 1 , but are also crucial for the development and homeostatic maintenance of normal healthy tissues, as well as in the repair of damaged tissue 2 . Hence, there is considerable interest in exploring how macrophages are tailored to the physiological demands of their environment, and how macrophage behaviour changes when homeostasis is perturbed.
Until recently, researchers thought that they could explain macrophage behavior by dividing them into discrete subsets ('M1-like' and 'M2-like') on the basis of their functional properties. However, work over the past few years has shown that this approach is oversimplistic 3 and that macrophages are highly heterogeneous, possessing specialized properties that are precisely adapted to individual tissues. In parallel, it is now clear that local factors in the environment control how macrophages develop and function under both steady-state and inflammatory conditions. Here we discuss how this new understanding of macrophage biology provides insights into the behavior of these cells in the most immunologically active tissues in the body: the barrier surfaces of the skin, intestine, lung and liver. Because these sites are exposed continuously to the external environment and are of crucial physiological importance, they require constant monitoring not only for pathogens, but also for maintenance of tissue integrity. As a result, immune cells in the barrier surfaces are subject to unique demands, and macrophage populations have developed many properties that are specifically adapted to each tissue. After discussing the processes that regulate macrophage function under steady-state conditions, we will then describe how these populations respond to local inflammation.
Macrophages in steady-state tissues
Macrophages are sessile mononuclear cells found in all tissues of the body, where they appear as large vacuolated cells with abundant cytoplasm containing lysosomal granules. Classically, tissue macrophages have been identified by their expression of the phenotypic markers F4/80 and CD68 in mice and humans, respectively. However, recent multi-parameter flow cytometric analyses and genome-wide transcriptional profiling have revealed additional generic markers that identify macrophages across a range of tissues 4 (Table 1) . Of particular note and of practical importance, expression of the high-affinity IgG receptor CD64 and the Mer tyrosine kinase (MerTK) associated with the uptake of apoptotic cells is common to most tissue macrophages in mice; these are not expressed highly by other mononuclear phagocytes, such as dendritic cells 5 .
Layered on top of this common signature, macrophages in individual tissues are remarkably heterogeneous in terms of their surface phenotype, transcriptome and epigenome ( Table 1) . Although many of their functions are conserved across tissues, including key housekeeping functions such as the clearance of apoptotic and senescent cells, individual populations of macrophages are highly adapted to the needs of their environment and fulfill roles specific to the particular tissue-and even subcompartments in tissues 6 . This heterogeneity is not surprising, given the substantial differences between organs in terms of their physiological functions, exposure to microbiota, nutrients and metabolites, and the fact that macrophages develop synchronously with their organ of residence 7 . For a time, it was thought that these differences might reflect distinct developmental origins of macrophages, but it now seems more likely that local environmental imprinting is the major determinant in macrophage identity and function, irrespective of their origin 8 . Given that the wider aspects of macrophage development have been reviewed recently and extensively elsewhere (e.g., see refs. 7-12), here we restrict our discussion to those aspects of macrophage origin and development that are specific to the barrier surfaces.
Intestinal macrophages
Macrophages are abundant in all layers of the normal small and large intestines, including the lamina propria of the mucosa, the muscularis externa and the serosa that separates the intestine from the peritoneal cavity. The largest population is in the lamina propria, where they are often found immediately below the single layer of columnar epithelium. In mice, mature macrophages of the lamina propria express high levels of major histocompatibility complex type II (MHCII) molecules, and most express CD11c (integrin α x )-normally found on dendritic cells-which often leads to difficulty in distinguishing between the two cell types in the intestine [13] [14] [15] [16] [17] (Table 1) . They are also rich in receptors associated with phagocytic activity and uptake of apoptotic cells, such as CD163, CD206, TIM4, α v β 5 integrin and CD36 (refs. 14,18-21) . Importantly, human intestinal macrophages share many of these features 14, 22 (Table 1) .
Unlike many other tissue-resident macrophages, those in the adult intestine are dependent on constant replenishment by bone marrow (BM)-derived monocytes, which then differentiate locally under the control of factors in the intestinal microenvironment, including transforming growth factor (TGF)-β 20, [23] [24] [25] (Fig. 1) . This continuous process allows for flexible adaptation to the mucosa, a highly dynamic tissue both in terms of its exposure to the various challenges that it faces from the outside world, and with regard to the rapid turnover of the epithelium. During their differentiation, mucosal macrophages progressively acquire their characteristic phenotype, together with a number of functions that contribute to homeostasis in the steadystate intestine (Fig. 1) . They have avid phagocytic activity and are bactericidal without exogenous stimulation, and, together with their subepithelial location, they are ideally situated to deal with pathogenic microbes that invade across the intestinal epithelium, as well as contribute to the symbiotic relationship with the microbiota 19, [25] [26] [27] .
Local macrophages can also help to preserve the integrity of the mucosa in a number of ways. First, their scavenger properties enable them to deal with the large amount of cell death that occurs routinely in this highly dynamic tissue. Second, they secrete mediators that drive epithelial cell renewal, including hepatocyte growth factor (HGF) 28 , members of the Wnt signaling pathway [29] [30] [31] and prostaglandin E2 (PGE2) 32 . Finally, they produce metalloproteinases that may promote tissue remodeling 20 . As a result, loss of mucosal macrophages in mice leads to dysregulated enterocyte differentiation and increased susceptibility to inflammatory damage (refs. 33,34 and Tissue macrophages under non-steady-state conditions).
A prominent feature of steady-state intestinal macrophages is their constitutive production of anti-inflammatory cytokine interleukin (IL)- 10 (refs. 14,21,35,36) , together with low levels of the proinflammatory mediators tumor necrosis factor (TNF)-α and IL-1β (refs. 14,37,38) . Despite the evidence of activation in situ, intestinal macrophages are unresponsive to exogenous stimuli and fail to produce nitric oxide, reactive oxygen species (ROS) or proinflammatory cytokines when stimulated by agents such as Toll-like receptor (TLR) ligands 14 . This does not reflect a failure to express appropriate patternrecognition receptors (PRRs), but rather may be due to active inhibitory mechanisms that block the relevant signaling pathways 22, 39, 40 . Signaling mediated by the IL-10 receptor has a crucial role in the functional 'anergy' of intestinal macrophages; defects in this pathway lead to macrophage hyperactivity and inflammatory bowel disease 21, [41] [42] [43] . The production of IL-10 by macrophages themselves is not essential for this process, and additional sources of this cytokine in the mucosa, such as CD4 + T cells, seem to be more important 21 .
Intestinal macrophages are also important sources of mediators that help to maintain other immune cells in their vicinity. Macrophagederived IL-10 sustains the expansion and survival of inducible FoxP3 + T regulatory (T reg ) cells in the lamina propria 35, 44 , a process that is important for tolerance to orally administered antigens 44 . In parallel, the numbers of endogenous FoxP3 + T cells in different segments of the intestine correlate with macrophage numbers 45 . IL-1β produced by mucosal macrophages may have similar roles in promoting the survival of local IL-17-producing CD4 + T cells 37 and in driving the secretion of colony-stimulating factor (CSF)-2 from type 3 innate lymphoid cells (ILC3) 38 . Mature intestinal macrophages also produce a number of chemokines that can recruit T cells and other immune cells, including their own monocyte precursors 17, 20 (Fig. 1) . The high expression of MHCII by steady-state intestinal macrophages raises questions of whether they can behave as antigen-presenting cells (APCs) in vivo. However, macrophages are sessile in the mucosa and do not migrate to the draining mesenteric lymph node (MLN) 13 . Therefore, they are unlikely to be important for priming naive T cells, which are found only in secondary lymphoid organs and not the mucosa. Whether macrophages might present antigens to T cells after their arrival in the mucosa remains to be resolved. Macrophages may also cooperate with mucosal dendritic cells during the induction of local immune responses through antigen transfer to migratory dendritic cells 46, 47 . Additionally, human intestinal macrophages are capable of producing retinoic acid by metabolism of dietary vitamin A, a property that is restricted to the intestinal dendritic cells in mice, and which could suggest that macrophages might assist the imprinting of gut homing in human T cells 48, 49 .
Are there specialized macrophage microenvironments in the intestine? Much of what we know about intestinal macrophages comes from studies using cells isolated from the lamina propria of whole tissue or biopsies. Thus, there is limited information on how macrophages might behave in the different anatomical compartments in the mucosa. There are relatively more macrophages in the lamina propria of the colon than in the small intestine 50 , which possibly reflects differences in the functions of and bacterial loads in these tissues.
Macrophages are found in a number of locations in the mucosa itself, ranging from immediately next to the basement membrane underlying the epithelium to the central core of the lamina propria, and at different positions along the villus-crypt axis (Fig. 1) . A specific population expressing CD169 is found near the crypt base, close to the submucosa, and these may have distinct functions and developmental requirements 51, 52 . Substantial numbers of macrophages are also found in the external muscularis layer of the intestine (Fig. 1) . These are morphologically, phenotypically and transcriptionally distinct from those in the lamina propria, selectively expressing a number of genes associated with tissue repair 53 . Being located close to neurons in submucosal ganglia, they also engage in two-way interactions with the enteric nervous system and respond to luminal Figure 1 Barrier-tissue macrophage function under homeostatic conditions. Resident macrophages in the lamina propria of the intestine express high levels of many receptors for apoptotic cells, ideal for clearing the large amounts of cell death found in this rapidly turning over tissue 14, [18] [19] [20] [21] [22] . The production of trophic factors for epithelial stem cells and tissue-remodeling metalloproteinases helps to maintain barrier integrity 20, [28] [29] [30] [31] [32] [33] [34] . Being actively phagocytic and bactericidal, lamina propria macrophages are crucial in shaping host-microbiota symbiosis, and may send processes across the epithelial barrier to sample contents of the lumen. They acquire many antigens avidly and pass these on to neighboring migratory dendritic cells for presentation to T cells in the draining mesenteric lymph node 46, 47 35, 44 and ILC3 cells 38 , and the release of chemokines such as CCL2 allows the macrophages to recruit their own monocyte precursors and other leukocytes 17, 20 . Macrophages in the muscularis mucosa are involved in two-way interactions with sympathetic neurons of the enteric nervous system and express high levels of the β2 adrenergic receptor (β2AR) 53, 54 . Signaling through the β2AR drives anti-inflammatory and prorepair properties in the macrophages, including the production of IL-10 and RELM-α, and bone morphogenic protein 2 (BMP2), produced by muscularis macrophages in response to microbial signals, regulates neuronal function 53, 54 .
bacteria through signals from noradrenergic nerves 54, 55 . It remains unknown whether the macrophages found in the muscularis layer are derived from different precursors from those in the lamina propria, and the local factors shaping their differentiation are also yet to be elucidated.
Lung macrophages
The lung harbors at least two different macrophage populations that occupy distinct anatomical niches (Fig. 2) . The largest of these inhabits the alveolar space (alveolar macrophages, AMs), where they represent ~90-95% of leukocytes and reside in a precisely defined niche on the luminal side of the lung alveoli. In both mice and humans, AMs can be identified by their high autofluorescence and expression of CD64, as well as high levels of CD11c integrin and CD169 (sialoadhesin) ( Table 1 ) 4, [56] [57] [58] . However, important phenotypic differences exist between alveolar macrophages in mice and humans ( Table 1) . For instance, although SiglecF is a signature molecule for mouse alveolar macrophages 4 , its functional paralog, Siglec8, is absent from human alveolar macrophages 58 ( Table 1) . Alveolar macrophages develop from fetal liver monocytes under the control of CSF2 (GM-CSF) in the first days of life, paralleling the development of the alveoli 59 ( Fig. 2) , and then maintain themselves by in situ self-renewal 57 .
One of the principal homeostatic functions of alveolar macrophages is regulating the levels of pulmonary surfactant, the proteolipid complex synthesized and secreted by the respiratory epithelium (Fig. 2) . Indeed, the transcriptional signature of alveolar macrophages features several genes implicated in lipid metabolism 4, 60 , and pulmonary alveolar proteinosis (PAP) develops owing to excessive surfactant accumulation when AM development is defective, for instance, in mice and humans in whom the CSF2-CSF2R axis has been disrupted 8 . CSF2 is produced predominantly by alveolar epithelial cells (AECs) and controls much of the unique phenotypic and functional identity of AM, including lipid catabolism and cytokine production through the induction of the transcription factor PPAR-γ 61, 62 . Alveolar macrophages also maintain the integrity of the alveolar space by removing senescent cells and inhaled particles, and by acting as a first line of defense against pathogens 63 . Similarly to intestinal macrophages, alveolar macrophages respond poorly to activation by TLR ligands and other stimuli 63, 64 , which allows them to scavenge and eliminate environmental antigens in a nonphlogistic manner. This hyporesponsive state is maintained by inhibitory receptors on alveolar macrophages, including CD200R, IL-10R and TGF-βR, which recognize their respective ligands on AECs 64 . The binding of epithelial-derived surfactant proteins (SPs), of which SP-A and SP-D are the most abundant, to receptors such as signal regulatory protein (SIRP)-α can also modify phagocytosis, cytokine production and TLR responsiveness of alveolar macrophages 65 . Alveolar macrophages are also crucial in maintaining airway tolerance to innocuous antigens by supporting the differentiation of antigen-specific T reg cells 66 . Alveolar macrophages may also directly regulate the reactivity of AECs to their environment through the release of exosomes and microvesicles containing suppressor of cytokine-signaling (SOCS) proteins 67 . Continual interaction with the AECs is also proposed to account for why alveolar macrophages remain relatively sessile under both steady-state conditions and after challenge with bacterial stimuli 68 . Figure 2 Alveolar macrophages in the lung are crucial for maintaining the patency of the alveolar space, where they regulate surfactant levels and phagocytose inhaled microbes and other particulate materials 59, 61 . They communicate intimately with alveolar epithelial cells, removing dead cells and controlling their renewal. Alveolar macrophages maintain an anti-inflammatory environment through the expression of inhibitory cytokines and receptors that regulate T cell responses and local innate immune reactions. Alveolar macrophages are derived from fetal liver monocytes during the neonatal period that subsequently self-renew for much of adult life 57, 59 . Alveolar macrophage differentiation is driven by CSF2 that induces the expression of the TF PPAR-γ 59, 61, 62 , whose ligands may include lipid-rich materials, such as surfactant, present in the alveolar space. Other TFs involved in alveolar macrophage development include Bach2 and C/EBP-β 180, 181 . The specific functions of steady-state interstitial macrophages are not yet known, but may include second-line defense against microbes, the promotion of anti-inflammatory T cell responses and shaping local dendritic cell functions 73 . The origin(s) of interstitial macrophages remain controversial 69, 70, 76, 77 , and the signals and transcription factors involved in their specification are yet to be determined. Macrophages are also found in the lung parenchyma (interstitium) between the alveoli and capillary beds (Fig. 2) . These interstitial macrophages (IMs) can be distinguished from alveolar macrophages by their distinct surface phenotype 4, 56, 58, 69 (Table 1) , and they have a unique transcriptional signature 70 . Similarly to those in the intestine, IMs are MHCII + and express variable levels of CD11c (refs. 4,58,69,71) , which can lead to their misclassification as DCs. Because different investigators have used divergent criteria to define IMs, there is limited understanding of their role in lung homeostasis [72] [73] [74] . However, a prominent feature of IMs is their constitutive production of the anti-inflammatory cytokine IL- 10 (refs. 73,74) , which is reported to control the immunogenicity of lung DCs 73 . Furthermore, they produce growth factors such as PDGF-β that are known to regulate fibroblast proliferation 75 . Although the developmental origin of IMs remains controversial 69, 70, 76, 77 , they have been shown to require replacement by monocytes, which suggests that different anatomical niches in the same tissue use distinct mechanisms to maintain their macrophage populations 69, 70, 76 . However, this might simply reflect differences in niche accessibility. For instance, whereas monocytes can easily access the lung parenchyma, entry to the alveolar space under normal physiological conditions might be impeded by the epithelial barrier 78 .
Skin macrophages
The skin consists of two anatomically distinct regions, the dermis and the epidermis, each of which contains phenotypically, developmentally and functionally distinct macrophage populations (Fig. 3) .
Langerhans cells are found in the stratified squamous epithelium of the epidermis and express the langerin molecule (CD207; see Table 1) responsible for the formation of the characteristic Birbeck granules found exclusively in Langerhans cells 78 . For many years, Langerhans cells were considered the archetypal nonlymphoid dendritic cells, but it is increasingly clear that they display features of both macrophages and dendritic cells 79 (Fig. 3) . As well as fulfilling classical dendritic cell functions, such as migration to draining LNs and antigen presentation 79 , mouse Langerhans cells express high levels of the DCspecific transcription factor Zbtb46 (ref. 80 ) and lack expression of the macrophage markers CD64 and MerTK 79 . Despite this, they can be distinguished from conventional type 2 dendritic cells (cDC2s) on the basis of their expression of CD24 and because they lack expression of the cDC marker, CD26 (ref. 81) ( Table 1) . Unlike dendritic cells, Langerhans cells are derived from fetal liver monocytes 7 , can exist autonomously from blood monocytes through in situ self-renewal and express the macrophage-restricted transcription factor MafB 80 . However substantial differences exist between murine and human Langerhans cells (Table 1) , with the latter sharing characteristics with cDC1s, including machinery for cross-presentation of antigens 82 . Unlike most other tissue macrophages, Langerhans cells rely on the alternative CSF1R ligand, IL-34, for their development, which is produced constitutively by keratinocytes 83, 84 . Keratinocyte-derived TGF-β is also indispensable for Langerhans cell development and maintenance 85 (Fig. 3) .
Given their ability to migrate to the draining LNs and act as antigen-presenting cells, Langerhans cells have been implicated in the initiation of immune responses. As discussed below, this can involve priming effector T cells in the context of infection. However, in steady-state conditions, they may have an intrinsically tolerogenic role 86 , and increased contact hypersensitivity to haptens has been Figure 3 Barrier-tissue macrophage function under homeostatic conditions. Langerhans cells in the epidermis have transcriptional and f unctional properties of both macrophages and dendritic cells 79, 80 . They are highly phagocytic and proficient at acquiring antigen from the environment, but can also transport this to draining lymph nodes and present it to T cells, helping to maintain tolerance in the steady state. Langerhans cells are derived from yolk-sac precursors and fetal liver monocytes 77, 89 , and their differentiation is regulated by TGF-β 85 and the CSF1R ligand IL-34 (ref. 83) , together with the transcription factors AhR and RUNX3. Dermal macrophages seem to include cells of both embryonic and BM-monocyte origin, with the latter being dominant in adult life 88 , but the factors involved in their differentiation and their tissuespecific roles remain to be determined.
described in mice lacking Langerhans cells 87 . Thus, Langerhans cells may be similar to other dendritic-cell-like antigen-presenting cells in their ability to adapt flexibly to the needs of their environment. The macrophage compartment of the underlying dermis is heterogeneous 79 , and these macrophages are phenotypically distinct from their epidermal neighbors in both mice and humans ( Table 1) 88 (Fig. 3) . Notably, mature dermal macrophages in mice can be either MHCII + or MHCII -, and, although the relationship between these phenotypic subsets remains unclear, they display differences in transcriptome and turnover kinetics 76, 88 . Dermal macrophages develop initially from embryonic progenitors, but, as in the intestine, these are displaced progressively by bone-marrow-derived monocytes 89 . Adult dermal MHCII + macrophages then require continuous replenishment from circulating monocytes 88 (Fig. 3) in a process influenced, in part, by the microbiota 88 . Apart from a clear role of CSF1R signaling 90 , so far, little is known regarding the factors that are involved in dermal macrophage differentiation. Whether MHCII-defined subsets exist in human skin remains unclear, because human leukocyte antigen (HLA)-DR expression is often used as the starting point for identifying mononuclear phagocytes in human skin 91, 92 . Although dermal macrophages are poor antigen-presenting cells 88 , as in the intestine, they may help to maintain the dermal T cell compartment 91 , possibly through their constitutive production of IL-10 (ref. 88) (Fig. 3) . They have also been proposed to act as sentinels of invasion, expressing a number of genes that are associated with the killing of microorganisms, and displaying avid phagocytic ability 88 .
Liver macrophages
Although not always thought of as a barrier tissue, the liver receives all blood that drains from the intestine through the portal vein, and the organ is thus continually exposed to products of both the diet and the microbiota. Kupffer cells are the principal macrophages of the liver, where they reside in the sinusoids in a perfect position to monitor materials emanating from the intestine (Fig. 4) . Kupffer cells develop during embryogenesis from yolk-sac precursors and fetal liver monocytes, which then self-renew throughout life 7 . However, circulating monocytes have also been shown to contribute (albeit at low levels) to the Kupffer cell pool during liver growth in the first few weeks of life 93 , and hematopoietic stem cell (HSC)-derived cells may also contribute to the Kupffer cell pool with age 94 . The precise signals that drive Kupffer cell differentiation remain unknown, but seem likely to be derived from the hepatic cells in close proximity to the Kupffer cells, such as liver sinusoidal endothelial cells, hepatocytes or hepatic stellate cells 8 .
As well as expressing generic macrophage markers, Kupffer cells express intermediate levels of CD11b and MHCII, which distinguishes them from other CD11b hi myeloid cells in the liver 93 (Table 1) . In addition, mouse Kupffer cells express high levels of the phagocytic receptor Tim4 (ref. 93, 95) , the complement receptor VSIG4 (or CRIg) 96, 97 and, uniquely among tissue macrophages, the C-type lectin Clec4F (refs. 23,93,98) ( Table 1) . Human hepatic macrophages express CD68, CD64 and CD163 (refs. 99,100), but whether these markers are restricted to Kupffer cells or are also present on other liver mononuclear phagocytes is unclear. Notably, although Clec4F is not conserved in humans, both VSIG4 and Tim4 are expressed by human Kupffer cells 96, 101 (Table 1) .
Kupffer cells have been suggested to act as a firewall that prevents systemic dissemination of microbes and their products from the intestine 102, 103 (Fig. 4) . The liver has been particularly associated with the induction of tolerance to orally administered proteins 104 , and the administration of antigen into the portal vein has been reported to induce systemic tolerance, whereas portal-vein shunting abrogates oral tolerance [105] [106] [107] [108] . Given their phagocytic capacity and their expression of MHCII, Kupffer cells have been suggested to be key to this process, both as antigen-presenting cells [109] [110] [111] [112] and by regulating the local immune environment through the production of immunosuppressive cytokines, including IL-10 and TGF-β 113, 114 . The normally tolerogenic properties of Kupffer cells, however, have been suggested to be overridden by stimuli such as TLR ligands, which implies that they could also have a role in active immunity against microbial infections [115] [116] [117] ; whether this represents true Kupffer cell plasticity or the presence of non-Kupffer cells that respond to TLRs, however, remains to be investigated.
Box 1 Macrophage behavior under nonhomeostatic conditions
Disruption of local homeostasis owing to inflammation or infection results in a drastically altered local environment, with damage to tissue cells and induction of an innate immune response. These lead to increased production of inflammatory cytokines and chemokines, together with the recruitment of inflammatory cells, including neutrophils and monocytes, the latter of which can differentiate into macrophages. An important unanswered question concerns the relative roles of newly recruited and pre-existing macrophages in inflammation (Fig. 5) . Although it is clear that recruited monocytes are sufficiently plastic to respond appropriately to the changing environment, there is less evidence that the tissue-resident macrophages can modify their homeostatic functions to become proinflammatory under such circumstances. Indeed, the findings that the tissue-conditioned properties of resident macrophages are determined at the level of the epigenome 23 would suggest that it may be difficult for these cells to change in response to new triggers, although this, too, is likely to be tissue-specific. Importantly, there is evidence that pre-existing tissue-resident and newly recruited inflammatory macrophages can respond differently to stimuli, at least in the peritoneal cavity, lung and liver 164, 179, 183 . This has clear implications for designing macrophage-targeted therapy in inflammation.
In many tissues, inflammation is associated with a reduction in the resident macrophage population, often referred to as the 'macrophage disappearance reaction'. The mechanisms responsible are likely to be specific to each inflammatory insult, but could include cell death, increased adherence to tissue stroma, or emigration from the tissue. A controversial topic is whether monocytes and/or macrophages can migrate from inflamed tissues to draining lymph nodes and present antigen to T cells, thus behaving as 'monocyte-derived dendritic cells'. This is a longstanding concept in myeloid cell biology, and, although macrophages do not migrate to lymph nodes under steady-state conditions, during inflammation in tissues such as the gut and lung, some monocytes may upregulate CCR7, migrate to draining lymph nodes and present antigen to naive T cells 184 . Given that these cells express the transcription factor MafB, but not Zbtb46, they seem to be macrophages rather than part of the genuine dendritic cell lineage 80 . Although this is likely a relatively rare process, it would clearly be an effective way of expanding the range of antigen-presenting cells capable of driving effector T cell responses in protective immunity, and it underlines the plasticity of recruited monocytes. Kupffer cells also have important homeostatic roles in iron metabolism and recycling 118 , and they express a number of genes involved in these processes, including Cd163, Slc40a1, Hmox1, Hpx and Scd1 (ref. 93) (Fig. 4) . These properties are shared with splenic red pulp macrophages, which are also exposed constantly to blood 95, 119 . The stimulation of iron metabolism in Kupffer cells by IL-6 and IL-1β can contribute to control of infection through the deprivation of iron from pathogens 120 . Indeed, individuals who have a deficiency of hepicidin, which induces the expression of a number of proteins involved in iron scavenging and sequestration in Kupffer cells, are more susceptible to infection with iron-dependent microbes [121] [122] [123] . The Kupffer cell transcriptome is also enriched for genes involved in lipid metabolism 93 , and Kupffer cells have been implicated in the pathogenesis of diseases associated with excessive lipid consumption, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) [124] [125] [126] .
Tissue macrophages under non-steady-state conditions One of the most important gaps in our current knowledge of tissue-resident macrophages is that the study of their behavior under nonhomeostatic conditions, such as infection and inflammatory disease, remains in its infancy (Box 1 and Fig. 5) . Below, we review what is known about barrier-tissue macrophages under these circumstances, focusing on work that is compatible with recent advances in our understanding of their phenotype and biology.
Intestinal macrophages
Intestinal disorders, such as inflammatory bowel disease and infection, are accompanied by intense infiltration with macrophages and monocytes 127 . The success of anti-TNF-α therapy in Crohn's disease highlights the practical relevance of understanding the underlying immunological processes. In both humans and animals, the majority of the infiltrate in inflamed mucosa is made up of monocytes and immature macrophages, whereas the numbers of mature macrophages are usually normal, or even reduced, when compared with those in the steady-state intestine 14, 15, 21, 128 . Furthermore, the relatively immature cells account for most of the proinflammatory mediators, such as IL-1β, IL-6, TNF-α, IL-23, NO and ROI [14] [15] [16] [17] [18] 128, 129 . As well as causing tissue damage and/or targeting microbes directly, these mediators can also activate other effector cells of the innate and adaptive immune system, such as monocytes, neutrophils, T helper 17 (T H 17) cells and T H 1 cells. Proinflammatory monocytes/macrophages also produce chemokines, such as CCL2, CCL3, CCL4, CCL5, CCL8 and CCL11, which recruit eosinophils and neutrophils, as well as more monocytes 51, 130, 131 . As in the steady-state intestine, the enhanced recruitment of monocytes into inflamed intestine is driven mostly by CCR2 (refs. 127,132) , although other chemokine-receptors, such as CCL3 and its receptor CCR1 (ref. 133) , might also contribute.
The monocytes that infiltrate the inflamed mucosa of humans and mice are phenotypically indistinguishable from those that replenish the mature macrophage pool under steady-state conditions. However, their development seems to be arrested before they can acquire substantial anti-inflammatory properties, such as the production of IL-10 or hyporesponsiveness to stimulation [14] [15] [16] . The reasons for this block in differentiation are unclear, although one possibility could be that the monocytes recruited to the inflamed intestine are already intrinsically different. A process of this kind has been found in murine Toxoplasmosis, in which IL-12 released from the inflamed mucosa alters monocyte differentiation in the bone marrow through the production of IFN-γ 134 , but this has not yet been explored in other contexts. Figure 4 Kupffer cells are located at the intersection of the enteric and peripheral circulatory systems. Thus, they are in an ideal position to act as a firewall against microbes and other factors arriving from the intestine in the portal veins 102, 103 , and they have been implicated in maintaining tolerance to these materials, either directly by presenting antigen to T cells, or by maintaining an immunosuppressive local environment [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] . Kupffer cells have a crucial role in recycling iron from senescent red blood cells, and they are also involved in the metabolism of lipids and transport of the resulting products into bile 95, 118 . Given that they are closely associated with other parenchymal cells, such as hepatocytes and liver sinusoidal endothelial cells (LSECs), it is likely that Kupffer cells might be important in the homeostasis of these cell types 8 . Kupffer cells develop from fetal liver monocyte precursors 89 , and this is driven by heme derived from the recycling of effete red blood cells 95 It is controversial whether the original fully mature macrophages also contribute to intestinal inflammation (Box 1 and Fig. 3) . Although mature resident macrophages do not become proinflammatory during experimental colitis induced by chemicals or T cells 14, 16, 18 , they can do so under conditions when inflammation occurs in the absence of IL-10-mediated control of macrophage activity 21, 129 . One population of resident macrophages that might contribute directly to inflammation is the group expressing CD169, which recruits monocyte neutrophils through the production of CCL8 (refs. 51, 52) . Furthermore, muscularis macrophages play an important part in the postoperative paralytic ileus by producing nitric oxide in response to local trauma, which leads to the activation of neighboring neurons 54 .
Macrophages also play a part in the protective immunity that expels large extracellular microorganisms, such as intestinal helminths 135, 136 . During such T H 2 responses, macrophages produce arginase and RELM-α 136,137 , together with chemokines that can recruit eosinophils and other effector cells 131 . This generates an environment detrimental to parasite survival, encouraging their expulsion. As in other forms of intestinal inflammation, newly recruited monocytes seem to be the most important source of activated, effector macrophages in these T H 2-dependent immune responses 136 . However, given that IL-4-dependent local proliferation and the activation of pre-existing resident macrophages has been described in parasite infection of the serous cavities 138 , similar processes might be feasible in the intestine.
Macrophages are important for tissue repair and the restoration of homeostasis after inflammation in the intestine. This may involve their ability to drive epithelial stem cell renewal 32, 139 , and IL-1-mediated induction of IL-22 from ILC3 helps to restore epithelial barrier function and has antimicrobial effects 132, 140 . Macrophages may also protect against intestinal inflammation induced by the chemical dextran sodium sulfate (DSS) by suppressing production of the Figure 5 Macrophages in barrier tissues under nonhomeostatic conditions. The disruption of homeostasis by infection or inflammation leads to the recruitment of Ly6C hi monocytes and other inflammatory leukocytes, such as neutrophils and eosinophils. The Ly6C hi monocytes generate inflammatory macrophages, and together, these are the main sources of mediators such as TNF-α, IL-1 and IL- 6 (refs. 17,177) . It seems that most of these monocytes do not differentiate into fully mature macrophages as they would under homeostatic conditions, owing to an arrest in this process, and so these inflammatory cells may be short-lived 14 . An additional source of proinflammatory macrophages during inflammation may be monocytes whose properties have already been programmed differently before leaving the bone marrow in response to signals generated in the inflamed tissue 134 . The role of the original tissue-resident macrophage population in inflammation remains unclear. These cells may act as early sentinels of tissue damage and recruit monocytes and granulocytes through the production of CCL2, CCL8, CCL11, CXCL2 and other chemokines. However, in many tissues, the numbers of resident macrophages are often reduced during the immediate response to tissue injury, the so-called macrophage disappearance reaction. Whether the remaining cells can alter their normal anti-inflammatory properties to contribute to pathology and protective immunity is not fully understood and may depend on the circumstances or tissue involved 14, 17, 138, 147, 164, 169, 177 . Many questions also remain unanswered regarding the fate of the monocytes and macrophages upon return to homeostasis. For example, do activated tissue-resident macrophages return to steady state? Do the recruited monocyte-derived macrophages die, persist in the tissue as monocyte-derived macrophages or become monocyte-derived tissue resident macrophages? Finally, it is unclear whether additional monocytes are recruited to help replenish the resident-macrophage niche, and how each of these cells might contribute to the tissue-repair process.
r e v i e w 1 2 6 6 VOLUME 23 | NUMBER 11 | NOVEMBER 2017 nature medicine alarmin IL-33 (ref. 141) , and their ability to produce arginase during T H 2-mediated immune responses is a crucial component of tissue repair after helminth infection 142, 143 . As a result of these properties, the depletion of macrophage delays recovery from experimental colitis 139, 141, 144 . Whether these are functions of pre-existing resident macrophages or of the monocytes recruited during the initial pathology is again unclear, although recent studies have shown that apparently proinflammatory monocytes recruited during murine Toxoplasmosis may protect against immunopathology by producing PGE 2 which suppresses neutrophil activation 128 . Both CSF2 and VEGF-C produced during inflammation have been shown to induce reparative properties in intestinal macrophages 145 .
Lung macrophages
Given their positioning in the airway, it is unsurprising that alveolar macrophages are key effector cells in the protective response against bacterial, viral and fungal infections. By virtue of their expression of a range of pattern-recognition receptors and high phagolysosomal capacity, alveolar macrophages excel at engulfing and destroying extracellular bacteria such as Streptococcus pneumonia 63 . Alveolar macrophages also orchestrate the recruitment of neutrophils and effector monocytes to the lung through the release of IL-1β, which induces CXCL8 production by the respiratory epithelium 146 . They are also potent producers of type 1 IFN in response to viral infections, and orchestrate the recruitment of antiviral monocytes 147 . Alveolar macrophages enhance viral clearance during influenza infection, and there is increased lung pathology in systems in which alveolar macrophages have been depleted 64, 148 . Conversely, the activation threshold of alveolar macrophages may be heightened following severe viral infection, which leaves individuals more susceptible to bacterial infections. This may involve changes in the expression of inhibitory ligands by AEC 64 . Alveolar macrophages have also been implicated in the development and progression of asthma, although it remains uncertain whether they have a pathogenic or protective role 149 . On one hand, the depletion of alveolar macrophages in mice worsens allergen-induced airway inflammation 150 , and adoptive transfer of normal alveolar macrophages can protect sensitized lungs from damage 150 . Moreover, alveolar macrophages from individuals with asthma produce more IL-10 than their counterparts from healthy lungs 151 . However, alveolar macrophages from allergen-sensitized mice are more able to stimulate T cell responses, and alveolar macrophages from patients with asthma express higher levels of costimulatory molecules such as CD80 (ref. 152) , which suggests that asthmatic alveolar macrophages might be able to promote pathogenic T H 2 responses, perhaps through their production of IL-13 (ref. 148) .
The role of interstitial macrophages in lung inflammation or infection is poorly understood, although they have been shown to confer protection against allergic airway inflammation by producing . Whether this is a property of resident interstitial macrophages or whether elicited monocyte-derived macrophages can also do this is unclear. Similarly, whether interstitial-macrophage-derived IL-10 plays an important part in other models of disease remains to be determined. Interstitial macrophages also release EGF, which has been suggested to promote alveolar fluid clearance through the promotion of epithelial sodium channels 154 .
Pulmonary macrophages are important in driving the fibrogenesis, matrix remodeling and re-epithelialization of the alveolar wall that are all essential for the restoration of barrier integrity and efficient gas exchange following lung injury. Alveolar macrophages produce multiple growth factors that promote re-epithelialization of the alveolar wall, including VEGF, PDGF, FGF, TGF-β 155, 156 . TNF-α from alveolar macrophages also upregulates CSF2 production from AECs, which stimulates AEC proliferation 157, 158 and supports alveolar macrophage maintenance. Efferocytosis of apoptotic cells also promotes proreparative functions of alveolar macrophages, including the production of PGE2, PAF and TGF-β 159 . Somewhat paradoxically, lung macrophages have been implicated in the pathogenesis of interstitial lung diseases, such as idiopathic pulmonary fibrosis (IPF), in which there is uncontrolled fibrogenesis. The relative roles of tissue-resident alveolar macrophages, interstitial macrophages and monocyte-derived infiltrating macrophages in this condition remain poorly understood 8 . For instance, although alveolar macrophages can promote the resolution of experimental bleomycininduced fibrosis 160 , alveolar macrophages from individuals with IPF produce many profibrotic mediators, including TGF-β 161 and CCL18 (ref. 162) , and the depletion of macrophages-alveolar or infiltrating-reduces fibrogenesis in the same model 163 . However, this could be explained by recent work demonstrating that the origin of alveolar macrophages can influence their function. Experimental fibrosis disrupts the autonomous renewal of alveolar macrophages, leading to the recruitment of BM-derived alveolar macrophages that are more profibrogenic than their resident counterparts 164 . How origin dictates function remains unclear, although one possibility is that resident and BM-derived alveolar macrophages might occupy different microanatomical niches, and that this controls their function. As discussed in Box 1, the roles of developmentally distinct macrophages in other settings have not been examined, including during pulmonary emphysema, in which case macrophages may also contribute to the loss of alveolar architecture through their enhanced production of the matrix metalloproteinases MMP1 and MMP12 (ref. 64 ).
Skin macrophages
Langerhans cells have been shown to induce active T H 17 responses during cutaneous Candida albicans infection 165 , and they can participate in effector CD8 + T cell priming in lymph nodes during Herpes simplex virus (HSV) infection, either by presenting antigens directly to T cells or after transfer to cDC1s 166, 167 . Recently, it was shown that CD1a on Langerhans cells can amplify T H 17-driven models of dermatitis and psoriasis 168 . Importantly, blocking CD1a through the administration of anti-CD1a antibodies significantly reduced skin inflammation 168 , providing a putative therapeutic option for individuals with T H 17-mediated skin diseases. Although phenotypically distinct (MHCII hi ) monocyte-derived Langerhans cells have been shown to accumulate during models of injury and inflammation 169 , it remains unclear whether these or pre-existing resident cells are responsible for the proinflammatory functions of Langerhans cells under these conditions.
Little is known regarding the roles of dermal macrophages under nonhomeostatic conditions. Dermal monocyte-derived cells have been shown to accumulate in and drive the development of psoriasis-like inflammation 79, 169 , but not in other forms of inflammation, such as contact-allergen-induced dermatitis 88 . Dermal macrophages may have a role in the first line of defense against pathogens, having been shown to induce neutrophil extravasation in response to local infection with Staphylococcus aureus 170 . Dermal macrophages are also essential for wound healing and the restoration of tissue integrity following mechanical skin injury. Again, the relative contribution of fully mature resident macrophages relative to elicited monocyte-derived cells is unclear, but macrophages are essential for neovascularization, collagen-fibril assembly and scab formation, in a process dependent on IL-4R signaling 171 . IL-4/IL-13-polarized dermal macrophages are also implicated in driving tissue fibrosis through their production of RELM-α, which promotes profibrotic collagen cross-linking by dermal fibroblasts 171 . A population of FMS-like tyrosine kinase 3 ligand (Flt3L)-dependent, migratory monocyte-derived dendritic cells has been reported in the dermis under both homeostatic and inflammatory conditions, but the exact nature of these cells remains unclear, as does their relationship to dermal macrophages (Box 1).
Liver macrophages
Kupffer cells have been implicated in several acute and chronic hepatic pathologies, including ischemia/reperfusion (I/R-) injury, acetaminophen hepatoxicity (AILI), liver fibrosis, alcoholic liver disease (ALD), viral hepatitis, nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC). However, contradictory findings have been reported on the exact roles of Kupffer cells in these conditions 172 . In I/R-injury, for example, both pathogenic and protective roles, driven by TNF-α, IL-1β and ROS and IL-10, respectively [173] [174] [175] , have been attributed to Kupffer cells. Analogous findings have been reported in viral hepatitis, in which Kupffer cells have been suggested to produce both antiviral mediators and to suppress protective immunity 176 . These contrasting conclusions may reflect the fact that previous studies did not distinguish between bona fide Kupffer cells and infiltrating monocytes/macrophages, or use depletion strategies that targeted all myeloid cells in the liver. More recent studies have attempted to explore the relative roles of these cell types in inflammatory liver pathology. Notably, Kupffer cells maintain their distinct transcriptional profile following acetaminophen-induced liver injury, remaining largely identical to their steady-state counterparts 177 . However, as the damage following paracetamol overdose is restricted anatomically, it will be interesting to determine whether specific Kupffer cells located in the damaged areas do respond to the injury, and whether this has perhaps been overlooked in the use of bulk transcriptomic techniques. Interestingly, the infiltrating monocytes/macrophages are thought to both aggravate the early stages of this disorder 178 and to be necessary for the subsequent resolution of the inflammation 177 . Notably, recruited monocyte-derived macrophages do not seem to develop into bona fide Kupffer cells under these conditions, instead generating short-lived macrophages 177 (C.L.S. unpublished observations). By contrast, monocyte-derived Kupffer cells can be found during Listeria monocytogenes infection 179 . In this infection, early uptake of bacteria triggers Kupffer cell death by necroptosis, and bacteria are subsequently eliminated by recruited monocyte-derived macrophages that later develop into bona fide Kupffer cells 179 . However, it remains to be seen whether Kupffer cell death following bacterial uptake is required for effective clearance of the bacteria and return to liver homeostasis; furthermore, the impact of macrophage origin on these functions requires further study (Box 1). Thus, there is still much to learn regarding the specific functions of Kupffer cells and recruited monocyte-derived macrophages in the liver under nonhomeostatic conditions. The use of the newly defined markers capable of discriminating between Kupffer cells and other recruited monocyte-derived macrophages, as well as investigating differences in microanatomical location, will be crucial for truly assessing macrophage function during these pathologies.
Summary and future perspectives
Many of the central dogmas about the origin and function of macrophages in barrier tissues have been completely revised in recent years, with an increasing awareness of their heterogeneity and diversity of physiological roles. Rather than being dependent on the cells' origins, the properties of macrophages are highly tissue specific and seem to be imprinted locally, which ensures precise adaptation to the demands of their environment. These properties offer clear possibilities for targeted therapeutic intervention, with the aim of restoring homeostasis. For this to be achieved, however, it is crucial to identify the factors that drive the specification of different tissue-resident macrophage populations under homeostatic conditions. Determining the relative contributions made by resident and infiltrating macrophages during infection or inflammation could create further options for preventing their recruitment or activation.
During recovery from inflammation or infection, the macrophage population typically returns to steady-state levels and can also contribute to the restoration of tissue homeostasis. Again, it is unclear whether these processes reflect differentiation of the recruited inflammatory monocytes/macrophages into macrophages with repair functions or through a second wave of monocyte recruitment and macrophage differentiation. Similarly, it is not known whether the replenishment of macrophage numbers occurs through the proliferation of the remaining resident macrophage population, through additional recruitment of monocytes or through a combination of these processes (Fig. 5) .
